Incomplete Revascularization in the Era of Drug-Eluting Stents

• Published in: JACC. Cardiovascular interventions Vol. 2; no. 1; pp. 17 - 25
• Main Authors: Hannan, Edward L., PhD, FACC, Wu, Chuntao, MD, PhD, Walford, Gary, MD, FACC, Holmes, David R., MD, FACC, Jones, Robert H., MD, FACC, Sharma, Samin, MD, FACC, King, Spencer B., MD, MACC
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 2009
• Subjects: Cardiovascular; incomplete revascularization; mortality; stent; stent; myocardial infarction; incomplete revascularization; IR; coronary artery bypass graft; CR; drug-eluting stent(s); Percutaneous Coronary Intervention Reporting System; PCIRS; DES; complete revascularization; PCI; mortality; chronic total occlusion; CABG; MI; percutaneous coronary interventions; CTO
• ISSN: 1936-8798; 1876-7605
• DOI: 10.1016/j.jcin.2008.08.021

Incomplete Revascularization in the Era of Drug-Eluting Stents: Impact on Adverse Outcomes Edward L. Hannan, Chuntao Wu, Gary Walford, David R. Holmes, Robert H. Jones, Samin Sharma, Spencer B. King III New York State's Percutaneous Coronary Intervention Reporting System was used to identify 11,294 stent patients with multivessel disease undergoing either incomplete revascularization or complete revascularization in 39 hospitals between October 1, 2003, and December 31, 2004, and these patients were followed through December 31, 2005. Incomplete revascularization was performed in a total of 7,795 patients (69.0%) and was associated with higher 18-month mortality (adjusted hazard ratio [HR]: 1.23, 95% confidence interval [CI]: 1.04 to 1.45) and higher 18-month myocardial infarction/mortality (adjusted HR: 1.27, 95% CI: 1.09 to 1.47). In conclusion, patients undergoing coronary stenting who receive incomplete revascularization experience more adverse outcomes even in the era of drug-eluting stents. This has implications for choice of procedure and post-procedural monitoring.